Mavoglurant Effective Against Cocaine Addiction in Phase 2 Trial
The drug company, Novartis, reports a significant decline in cocaine use with mavoglurant in phase 2 trial.
Latest developments in causes and treatments
The drug company, Novartis, reports a significant decline in cocaine use with mavoglurant in phase 2 trial.